Tetraspanins as master organizers of the plasma membrane

Cell Membrane Nanodomains: From Biochemistry to Nanoscopy

Volumn , Issue , 2014, Pages 59-86

  Miranti, Cindy K ^a   Bergsma, Alexis ^b   Van Spriel, Annemiek B ^c  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

^b VAN ANDEL INSTITUTE   (United States)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; CYTOLOGY; PHOSPHOLIPIDS;

BIOLOGICAL FUNCTIONS; BIOPHYSICAL PROPERTIES; CELL MEMBRANE MODELS; EXTRACELLULAR STIMULI; INTRACELLULAR SIGNALS; MEMBRANE COMPARTMENT; MOLECULAR MECHANISM; TRANS-MEMBRANE PROTEINS;

PROTEINS;

EID: 85047417338     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b17634     Document Type: Chapter

References (126)

1. Singer, S. J., and G. L. Nicolson. “The Fluid Mosaic Model of the Structure of Cell Membranes.” Science 175, no. 4023 (1972): 720–31.
2. Laude, A. J., and I. A. Prior. “Plasma Membrane Microdomains: Organization, Function and Trafficking.” Mol Membr Biol 21, no. 3 (2004): 193–205.
3. Lingwood, D., and K. Simons. “Lipid Rafts as a Membrane-Organizing Principle.” Science 327, no. 5961 (2010): 46–50.
4. Simons, K., and J. L. Sampaio. “Membrane Organization and Lipid Rafts.” Cold Spring Harb Perspect Biol 3, no. 10 (2011): a004697.
5. Kusumi, A., T. K. Fujiwara, R. Chadda et al. “Dynamic Organizing Principles of the Plasma Membrane That Regulate Signal Transduction: Commemorating the Fortieth Anniversary of Singer and Nicolson’s Fluid-Mosaic Model.” Annu Rev Cell Dev Biol 28 (2012): 215–50.
6. Stipp, C. S., T. V. Kolesnikova, and M. E. Hemler. “Functional Domains in Tetraspanin Proteins.” Trends Biochem Sci 28, no. 2 (2003): 106–12.
7. Boucheix, C., and E. Rubinstein. “Tetraspanins.” Cell Mol Life Sci 58, no. 9 (2001): 1189–205.
8. Tarrant, J. M., L. Robb, A. B. van Spriel, and M. D. Wright. “Tetraspanins: Molecular Organisers of the Leukocyte Surface.” Trends Immunol 24, no. 11 (2003): 610–7.
9. Hemler, M. E. “Tetraspanin Functions and Associated Microdomains.” Nat Rev Mol Cell Biol 6, no. 10 (2005): 801–11.
10. Levy, S., and T. Shoham. “The Tetraspanin Web Modulates Immune-Signalling Complexes.” Nat Rev Immunol 5, no. 2 (2005): 136–48.
11. Hemler, M. E. “Tetraspanin Proteins Mediate Cellular Penetration, Invasion, and Fusion Events and Define a Novel Type of Membrane Microdomain.” Annu Rev Cell Dev Biol 19 (2003): 397–422.
12. Charrin, S., F. le Naour, O. Silvie et al. “Lateral Organization of Membrane Proteins: Tetraspanins Spin Their Web.” Biochem J 420, no. 2 (2009): 133–54.
13. Sala-Valdes, M., A. Ursa, S. Charrin et al. “EWI-2 and EWI-F Link the Tetraspanin Web to the Actin Cytoskeleton through Their Direct Association with Ezrin–Radixin–Moesin Proteins.” J Biol Chem 281, no. 28 (2006): 19665–75.
14. Claas, C., C. S. Stipp, and M. E. Hemler. “Evaluation of Prototype Transmembrane 4 Superfamily Protein Complexes and Their Relation to Lipid Rafts.” J Biol Chem 276, no. 11 (2001): 7974–84.
15. Le Naour, F., M. Andre, C. Boucheix, and E. Rubinstein. “Membrane Microdomains and Proteomics: Lessons from Tetraspanin Microdomains and Comparison with Lipid Rafts.” Proteomics 6, no. 24 (2006): 6447–54.
16. Espenel, C., E. Margeat, P. Dosset et al. “Single-Molecule Analysis of CD9 Dynamics and Partitioning Reveals Multiple Modes of Interaction in the Tetraspanin Web.” J Cell Biol 182, no. 4 (2008): 765–76.
17. Charrin, S., S. Manie, C. Thiele et al. “A Physical and Functional Link between Cholesterol and Tetraspanins.” Eur J Immunol 33, no. 9 (2003): 2479–89.
18. Zuidscherwoude, M., C. M. de Winde, A. Cambi, and A. B. van Spriel. “Microdomains in the membrane landscape shape antigen-presenting cell function.” J Leukoc Biol 95, no. 2 (2014): 251–63.
19. Yanez-Mo, M., O. Barreiro, M. Gordon-Alonso, M. Sala-Valdes, and F. Sanchez-Madrid. “Tetraspanin-Enriched Microdomains: A Functional Unit in Cell Plasma Membranes.” Trends Cell Biol 19, no. 9 (2009): 434–46.
20. Barreiro, O., M. Zamai, M. Yanez-Mo et al. “Endothelial Adhesion Receptors Are Recruited to Adherent Leukocytes by Inclusion in Preformed Tetraspanin Nanoplatforms.” J Cell Biol 183, no. 3 (2008): 527–42.
21. Lidke, D. S., and B. S. Wilson. “Caught in the Act: Quantifying Protein Behaviour in Living Cells.” Trends Cell Biol 19, no. 11 (2009): 566–74.
22. Berditchevski, F., E. Gilbert, M. R. Griffiths et al. “Analysis of the CD151-Alpha3beta1 Integrin and CD151-Tetraspanin Interactions by Mutagenesis.” J Biol Chem 276, no. 44 (2001): 41165–74.
23. Sterk, L. M., C. A. Geuijen, J. G. van den Berg et al. “Association of the Tetraspanin CD151 with the Laminin-Binding Integrins Alpha3beta1, Alpha6beta1, Alpha6beta4 and Alpha7beta1 in Cells in Culture and In Vivo.” J Cell Sci 115, Pt 6 (2002): 1161–73.
24. Sterk, L. M., C. A. Geuijen, L. C. Oomen et al. “The Tetraspan Molecule CD151, a Novel Constituent of Hemidesmosomes, Associates with the Integrin Alpha6beta4 and May Regulate the Spatial Organization of Hemidesmosomes.” J Cell Biol 149, no. 4 (2000): 969–82.
25. Yang, X., O. V. Kovalenko, W. Tang et al. “Palmitoylation Supports Assembly and Function of Integrin-Tetraspanin Complexes.” J Cell Biol 167, no. 6 (2004): 1231–40.
26. Berditchevski, F., E. Odintsova, S. Sawada, and E. Gilbert. “Expression of the Palmitoylation-Deficient CD151 Weakens the Association of Alpha 3 Beta 1 Integrin with the Tetraspanin-Enriched Microdomains and Affects Integrin-Dependent Signaling.” J Biol Chem 277, no. 40 (2002): 36991–7000.
27. van Spriel, A. B., S. de Keijzer, A. van der Schaaf et al. “The Tetraspanin CD37 Orchestrates the Alpha(4)Beta(1) Integrin-Akt Signaling Axis and Supports Long-Lived Plasma Cell Survival.” Sci Signal 5, no. 250 (2012): ra82.
28. van Spriel, A. B. “Tetraspanins in the Humoral Immune Response.” Biochem Soc Trans 39, no. 2 (2011): 512–7.
29. Feigelson, S. W., V. Grabovsky, R. Shamri, S. Levy, and R. Alon. “The CD81 Tetraspanin Facilitates Instantaneous Leukocyte VLA-4 Adhesion Strengthening to Vascular Cell Adhesion Molecule 1 (VCAM-1) under Shear Flow.” J Biol Chem 278, no. 51 (2003): 51203–12.
30. Bradbury, L. E., G. S. Kansas, S. Levy, R. L. Evans, and T. F. Tedder. “The CD19/CD21 Signal Transducing Complex of Human B Lymphocytes Includes the Target of Antiproliferative Antibody-1 and Leu-13 Molecules.” J Immunol 149, no. 9 (1992): 2841–50.
31. van Zelm, M. C., J. Smet, B. Adams et al. “CD81 Gene Defect in Humans Disrupts CD19 Complex Formation and Leads to Antibody Deficiency.” J Clin Invest 120, no. 4 (2010): 1265–74.
32. Shoham, T., R. Rajapaksa, C. C. Kuo, J. Haimovich, and S. Levy. “Building of the Tetraspanin Web: Distinct Structural Domains of CD81 Function in Different Cellular Compartments.” Mol Cell Biol 26, no. 4 (2006): 1373–85.
33. Mattila, P. K., C. Feest, D. Depoil et al. “The Actin and Tetraspanin Networks Organize Receptor Nanoclusters to Regulate B Cell Receptor-Mediated Signaling.” Immunity 38, no. 3 (2013): 461–74.
34. Wright, M. D., G. W. Moseley, and A. B. van Spriel. “Tetraspanin Microdomains in Immune Cell Signalling and Malignant Disease.” Tissue Antigens 64, no. 5 (2004): 533–42.
35. Zoller, M. “Tetraspanins: Push and Pull in Suppressing and Promoting Metastasis.” Nat Rev Cancer 9, no. 1 (2009): 40–55.
36. Sala-Valdes, M., N. Ailane, C. Greco, E. Rubinstein, and C. Boucheix. “Targeting Tetraspanins in Cancer.” Expert Opin Ther Targets 16, no. 10 (2012): 985–97.
37. Richardson, M. M., L. K. Jennings, and X. A. Zhang. “Tetraspanins and Tumor Progression.” Clin Exp Metastasis 28, no. 3 (2011): 261–70.
38. Liu, W. M., and X. A. Zhang. “KAI1/CD82, a Tumor Metastasis Suppressor.” Cancer Lett 240, no. 2 (2006): 183–94.
39. Miranti, C. K. “Controlling Cell Surface Dynamics and Signaling: How CD82/KAI1 Suppresses Metastasis.” Cell Signal 21, no. 2 (2009): 196–211.
40. Zhou, B., L. Liu, M. Reddivari, and X. A. Zhang. “The Palmitoylation of Metastasis Suppressor KAI1/CD82 Is Important for Its Motility- and Invasiveness-Inhibitory Activity.” Cancer Res 64, no. 20 (2004): 7455–63.
41. Zijlstra, A., J. Lewis, B. Degryse, H. Stuhlmann, and J. P. Quigley. “The Inhibition of Tumor Cell Intravasation and Subsequent Metastasis via Regulation of In Vivo Tumor Cell Motility by the Tetraspanin CD151.” Cancer Cell 13, no. 3 (2008): 221–34.
42. Stipp, C. S. “Laminin-Binding Integrins and Their Tetraspanin Partners as Potential Antimetastatic Targets.” Expert Rev Mol Med 12 (2010): e3.
43. Sadej, R., H. Romanska, G. Baldwin et al. “CD151 Regulates Tumorigenesis by Modulating the Communication between Tumor Cells and Endothelium.” Mol Cancer Res 7, no. 6 (2009): 787–98.
44. Klosek, S. K., K. Nakashiro, S. Hara et al. “CD151 Regulates HGF-Stimulated Morphogenesis of Human Breast Cancer Cells.” Biochem Biophys Res Commun 379, no. 4 (2009): 1097–100.
45. Sadej, R., H. Romanska, D. Kavanagh et al. “Tetraspanin CD151 Regulates Transforming Growth Factor Beta Signaling: Implication in Tumor Metastasis.” Cancer Res 70, no. 14 (2010): 6059–70.
46. Yanez-Mo, M., F. Sanchez-Madrid, and C. Cabanas. “Membrane Proteases and Tetraspanins.” Biochem Soc Trans 39, no. 2 (2011): 541–6.
47. Yanez-Mo, M., O. Barreiro, P. Gonzalo et al. “MT1-MMP Collagenolytic Activity Is Regulated through Association with Tetraspanin CD151 in Primary Endothelial Cells.” Blood 112, no. 8 (2008): 3217–26.
48. Lafleur, M. A., D. Xu, and M. E. Hemler. “Tetraspanin Proteins Regulate Membrane Type-1 Matrix Metalloproteinase-Dependent Pericellular Proteolysis.” Mol Biol Cell 20, no. 7 (2009): 2030–40.
49. Haining, E. J., J. Yang, R. L. Bailey et al. “The TspanC8 Subgroup of Tetraspanins Interacts with a Disintegrin and Metalloprotease 10 (ADAM10) and Regulates Its Maturation and Cell Surface Expression.” J Biol Chem 287, no. 47 (2012): 39753–65.
50. Dornier, E., F. Coumailleau, J. F. Ottavi et al. “TspanC8 Tetraspanins Regulate ADAM10/Kuzbanian Trafficking and Promote Notch Activation in Flies and Mammals.” J Cell Biol 199, no. 3 (2012): 481–96.
51. Charrin, S., S. Manie, M. Oualid et al. “Differential Stability of Tetraspanin/Tetraspanin Interactions: Role of Palmitoylation.” FEBS Lett 516, no. 1–3 (2002): 139–44.
52. Zevian, S., N. E. Winterwood, and C. S. Stipp. “Structure-Function Analysis of Tetraspanin CD151 Reveals Distinct Requirements for Tumor Cell Behaviors Mediated by Alpha3beta1 Versus Alpha6beta4 Integrin.” J Biol Chem 286, no. 9 (2011): 7496–506.
53. Wang, H. X., T. V. Kolesnikova, C. Denison, S. P. Gygi, and M. E. Hemler. “The C-Terminal Tail of Tetraspanin Protein CD9 Contributes to Its Function and Molecular Organization.” J Cell Sci 124, Pt 16 (2011): 2702–10.
54. Delaguillaumie, A., C. Lagaudriere-Gesbert, M. R. Popoff, and H. Conjeaud. “Rho GTPases Link Cytoskeletal Rearrangements and Activation Processes Induced via the Tetraspanin CD82 in T Lymphocytes.” J Cell Sci 115, Pt 2 (2002): 433–43.
55. Sridhar, S. C., and C. K. Miranti. “Tetraspanin KAI1/CD82 Suppresses Invasion by Inhibiting Integrin-Dependent Crosstalk with c-Met Receptor and Src Kinases.” Oncogene 25, no. 16 (2006): 2367–78.
56. Todeschini, A. R., J. N. Dos Santos, K. Handa, and S. I. Hakomori. “Ganglioside GM2/GM3 Complex Affixed on Silica Nanospheres Strongly Inhibits Cell Motility through CD82/cMet-Mediated Pathway.” Proc Natl Acad Sci U S A 105, no. 6 (2008): 1925–30.
57. Knudsen, B. S., and M. Edlund. “Prostate Cancer and the Met Hepatocyte Growth Factor Receptor.” Adv Cancer Res 91 (2004): 31–67.
58. Klosek, S. K., K. Nakashiro, S. Hara et al. “CD151 Forms a Functional Complex with c-Met in Human Salivary Gland Cancer Cells.” Biochem Biophys Res Commun 336, no. 2 (2005): 408–16.
59. Franco, M., C. Muratori, S. Corso et al. “The Tetraspanin CD151 Is Required for Met-Dependent Signaling and Tumor Cell Growth.” J Biol Chem 285, no. 50 (2010): 38756–64.
60. Michieli, P., M. Mazzone, C. Basilico et al. “Targeting the Tumor and Its Microenvironment by a Dual-Function Decoy Met Receptor.” Cancer Cell 6, no. 1 (2004): 61–73.
61. Zhu, G. H., C. Huang, Z. J. Qiu et al. “Expression and Prognostic Significance of CD151, c-Met, and Integrin Alpha3/Alpha6 in Pancreatic Ductal Adenocarcinoma.” Dig Dis Sci 56, no. 4 (2011): 1090–8.
62. Odintsova, E., T. Sugiura, and F. Berditchevski. “Attenuation of EGF Receptor Signaling by a Metastasis Suppressor, the Tetraspanin CD82/KAI-1.” Curr Biol 10, no. 16 (2000): 1009–12.
63. Odintsova, E., J. Voortman, E. Gilbert, and F. Berditchevski. “Tetraspanin CD82 Regulates Compartmentalisation and Ligand-Induced Dimerization of EGFR.” J Cell Sci 116, Pt 22 (2003): 4557–66.
64. Odintsova, E., G. van Niel, H. Conjeaud et al. “Metastasis Suppressor Tetraspanin CD82/KAI1 Regulates Ubiquitylation of Epidermal Growth Factor Receptor.” J Biol Chem 288, no. 36 (2013): 26323–34.
65. Zhang, X. A., A. L. Bontrager, and M. E. Hemler. “Transmembrane-4 Superfamily Proteins Associate with Activated Protein Kinase C (PKC) and Link PKC to Specific Beta(1) Integrins.” J Biol Chem 276, no. 27 (2001): 25005–13.
66. Li, Q., X. H. Yang, F. Xu et al. “Tetraspanin CD151 Plays a Key Role in Skin Squamous Cell Carcinoma.” Oncogene 32, no. 14 (2013): 1772–83.
67. Wang, X. Q., Q. Yan, P. Sun et al. “Suppression of Epidermal Growth Factor Receptor Signaling by Protein Kinase C-Alpha Activation Requires CD82, Caveolin-1, and Ganglioside.” Cancer Res 67, no. 20 (2007): 9986–95.
68. Ford, D. A., C. C. Horner, and R. W. Gross. “Protein Kinase C Acylation by Palmitoyl Coenzyme a Facilitates Its Translocation to Membranes.” Biochemistry 37, no. 34 (1998): 11953–61.
69. Sharma, C., X. H. Yang, and M. E. Hemler. “DHHC2 Affects Palmitoylation, Stability, and Functions of Tetraspanins CD9 and CD151.” Mol Biol Cell 19, no. 8 (2008): 3415–25.
70. Rahimi, N., W. Hung, E. Tremblay, R. Saulnier, and B. Elliott. “C-Src Kinase Activity Is Required for Hepatocyte Growth Factor-Induced Motility and Anchorage-Independent Growth of Mammary Carcinoma Cells.” J Biol Chem 273, no. 50 (1998): 33714–21.
71. Zhang, X. A., B. He, B. Zhou, and L. Liu. “Requirement of the p130CAS-Crk Coupling for Metastasis Suppressor KAI1/CD82-Mediated Inhibition of Cell Migration.” J Biol Chem 278, no. 29 (2003): 27319–28.
72. Oneyama, C., T. Iino, K. Saito et al. “Transforming Potential of Src Family Kinases Is Limited by the Cholesterol-Enriched Membrane Microdomain.” Mol Cell Biol 29, no. 24 (2009): 6462–72.
73. Xu, C., Y. H. Zhang, M. Thangavel et al. “CD82 Endocytosis and Cholesterol-Dependent Reorganization of Tetraspanin Webs and Lipid Rafts.” FASEB J 23, no. 10 (2009): 3273–88.
74. Park, J. J., Y. B. Jin, Y. J. Lee et al. “KAI1 Suppresses HIF-1alpha and VEGF Expression by Blocking CDCP1-Enhanced Src Activation in Prostate Cancer.” BMC Cancer 12 (2012): 81.
75. Alvares, S. M., C. A. Dunn, T. A. Brown, E. E. Wayner, and W. G. Carter. “The Role of Membrane Microdomains in Transmembrane Signaling through the Epithelial Glycoprotein Gp140/CDCP1.” Biochim Biophys Acta 1780, no. 3 (2008): 486–96.
76. Stahelin, R. V., K. F. Kong, S. Raha et al. “Protein Kinase Ctheta C2 Domain Is a Phosphotyrosine Binding Module That Plays a Key Role in Its Activation.” J Biol Chem 287, no. 36 (2012): 30518–28.
77. Abe, M., T. Sugiura, M. Takahashi et al. “A Novel Function of CD82/KAI-1 on E-Cadherin-Mediated Homophilic Cellular Adhesion of Cancer Cells.” Cancer Lett 266, no. 2 (2008): 163–70.
78. Johnson, J. L., N. Winterwood, K. A. DeMali, and C. S. Stipp. “Tetraspanin CD151 Regulates Rhoa Activation and the Dynamic Stability of Carcinoma Cell-Cell Contacts.” J Cell Sci 122, Pt 13 (2009): 2263–73.
79. Kovalenko, O. V., X. H. Yang, and M. E. Hemler. “A Novel Cysteine Cross-Linking Method Reveals a Direct Association between Claudin-1 and Tetraspanin CD9.” Mol Cell Proteomics 6, no. 11 (2007): 1855–67.
80. Harris, H. J., M. J. Farquhar, C. J. Mee et al. “CD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry.” J Virol 82, no. 10 (2008): 5007–20.
81. Tiwari-Woodruff, S. K., A. G. Buznikov, T. Q. Vu et al. “Osp/Claudin-11 Forms a Complex with a Novel Member of the Tetraspanin Super Family and Beta1 Integrin and Regulates Proliferation and Migration of Oligodendrocytes.” J Cell Biol 153, no. 2 (2001): 295–305.
82. Nubel, T., J. Preobraschenski, H. Tuncay et al. “Claudin-7 Regulates EpCAM-Mediated Functions in Tumor Progression.” Mol Cancer Res 7, no. 3 (2009): 285–99.
83. Hong, I. K., D. I. Jeoung, K. S. Ha, Y. M. Kim, and H. Lee. “Tetraspanin CD151 Stimulates Adhesion-Dependent Activation of Ras, Rac, and Cdc42 by Facilitating Molecular Association between Beta1 Integrins and Small GTPases.” J Biol Chem 287, no. 38 (2012): 32027–39.
84. Sawada, S., M. Yoshimoto, E. Odintsova, N. A. Hotchin, and F. Berditchevski. “The Tetraspanin CD151 Functions as a Negative Regulator in the Adhesion-Dependent Activation of Ras.” J Biol Chem 278, no. 29 (2003): 26323–6.
85. Tejera, E., V. Rocha-Perugini, S. Lopez-Martin et al. “CD81 Regulates Cell Migration through Its Association with Rac GTPase.” Mol Biol Cell 24, no. 3 (2013): 261–73.
86. Choi, U. J., B. K. Jee, Y. Lim, and K. H. Lee. “KAI1/CD82 Decreases Rac1 Expression and Cell Proliferation through PI3K/Akt/mTOR Pathway in H1299 Lung Carcinoma Cells.” Cell Biochem Funct 27, no. 1 (2009): 40–7.
87. Quast, T., F. Eppler, V. Semmling et al. “CD81 Is Essential for the Formation of Membrane Protrusions and Regulates Rac1-Activation in Adhesion-Dependent Immune Cell Migration.” Blood 118, no. 7 (2011): 1818–27.
88. Zhang, X. A., W. S. Lane, S. Charrin, E. Rubinstein, and L. Liu. “EWI2/PGRL Associates with the Metastasis Suppressor KAI1/CD82 and Inhibits the Migration of Prostate Cancer Cells.” Cancer Res 63, no. 10 (2003): 2665–74.
89. Coffey, G. P., R. Rajapaksa, R. Liu et al. “Engagement of CD81 Induces Ezrin Tyrosine Phosphorylation and Its Cellular Redistribution with Filamentous Actin.” J Cell Sci 122, Pt 17 (2009): 3137–44.
90. Lapalombella, R., Y. Y. Yeh, L. Wang et al. “Tetraspanin CD37 Directly Mediates Transduction of Survival and Apoptotic Signals.” Cancer Cell 21, no. 5 (2012): 694–708.
91. Rous, B. A., B. J. Reaves, G. Ihrke et al. “Role of Adaptor Complex AP-3 in Targeting Wild-Type and Mutated CD63 to Lysosomes.” Mol Biol Cell 13, no. 3 (2002): 1071–82.
92. Liu, L., B. He, W. M. Liu et al. “Tetraspanin CD151 Promotes Cell Migration by Regulating Integrin Trafficking.” J Biol Chem 282, no. 43 (2007): 31631–42.
93. Artavanis-Tsakonas, K., P. V. Kasperkovitz, E. Papa et al. “The Tetraspanin CD82 Is Specifically Recruited to Fungal and Bacterial Phagosomes Prior to Acidification.” Infect Immun 79, no. 3 (2011): 1098–106.
94. He, B., L. Liu, G. A. Cook et al. “Tetraspanin CD82 Attenuates Cellular Morphogenesis through Down-Regulating Integrin Alpha6-Mediated Cell Adhesion.” J Biol Chem 280, no. 5 (2005): 3346–54.
95. Todeschini, A. R., J. N. Dos Santos, K. Handa, and S. I. Hakomori. “Ganglioside GM2-Tetraspanin CD82 Complex Inhibits Met and Its Cross-Talk with Integrins, Providing a Basis for Control of Cell Motility through Glycosynapse.” J Biol Chem 282, no. 11 (2007): 8123–33.
96. Shoham, T., R. Rajapaksa, C. Boucheix et al. “The Tetraspanin CD81 Regulates the Expression of CD19 during B Cell Development in a Postendoplasmic Reticulum Compartment.” J Immunol 171, no. 8 (2003): 4062–72.
97. Cannon, K. S., and P. Cresswell. “Quality Control of Transmembrane Domain Assembly in the Tetraspanin CD82.” EMBO J 20, no. 10 (2001): 2443–53.
98. Berditchevski, F., and E. Odintsova. “Tetraspanins as Regulators of Protein Trafficking.” Traffic 8, no. 2 (2007): 89–96.
99. Petersen, S. H., E. Odintsova, T. A. Haigh et al. “The Role of Tetraspanin CD63 in Antigen Presentation via MHC Class II.” Eur J Immunol 41, no. 9 (2011): 2556–61.
100. Nazarenko, I., S. Rana, A. Baumann et al. “Cell Surface Tetraspanin Tspan8 Contributes to Molecular Pathways of Exosome-Induced Endothelial Cell Activation.” Cancer Res 70, no. 4 (2010): 1668–78.
101. Luga, V., L. Zhang, A. M. Viloria-Petit et al. “Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration.” Cell 151, no. 7 (2012): 1542–56.
102. Le Naour, F., E. Rubinstein, C. Jasmin, M. Prenant, and C. Boucheix. “Severely Reduced Female Fertility in CD9-Deficient Mice.” Science 287, no. 5451 (2000): 319–21.
103. Miyado, K., G. Yamada, S. Yamada et al. “Requirement of CD9 on the Egg Plasma Membrane for Fertilization.” Science 287, no. 5451 (2000): 321–4.
104. Kaji, K., S. Oda, T. Shikano et al. “The Gamete Fusion Process Is Defective in Eggs of CD9-Deficient Mice.” Nat Genet 24, no. 3 (2000): 279–82.
105. Rubinstein, E., A. Ziyyat, M. Prenant et al. “Reduced Fertility of Female Mice Lacking CD81.” Dev Biol 290, no. 2 (2006): 351–8.
106. Rubinstein, E., A. Ziyyat, J. P. Wolf, F. Le Naour, and C. Boucheix. “The Molecular Players of Sperm-Egg Fusion in Mammals.” Semin Cell Dev Biol 17, no. 2 (2006): 254–63.
107. Zhu, G. Z., B. J. Miller, C. Boucheix et al. “Residues SFQ (173–175) in the Large Extracellular Loop of CD9 Are Required for Gamete Fusion.” Development 129, no. 8 (2002): 1995–2002.
108. Miyado, K., K. Yoshida, K. Yamagata et al. “The Fusing Ability of Sperm Is Bestowed by CD9-Containing Vesicles Released from Eggs in Mice.” Proc Natl Acad Sci U S A 105, no. 35 (2008): 12921–6.
109. Potel, J., P. Rassam, C. Montpellier et al. “EWI-2wint Promotes CD81 Clustering That Abrogates Hepatitis C Virus Entry.” Cell Microbiol 15, no. 7 (2013): 1234–52.
110. Montpellier, C., B. A. Tews, J. Poitrimole et al. “Interacting Regions of CD81 and Two of Its Partners, EWI-2 and EWI-2wint, and Their Effect on Hepatitis C Virus Infection.” J Biol Chem 286, no. 16 (2011): 13954–65.
111. Davis, C., H. J. Harris, K. Hu et al. “In Silico Directed Mutagenesis Identifies the CD81/Claudin-1 Hepatitis C Virus Receptor Interface.” Cell Microbiol 14, no. 12 (2012): 1892–903.
112. Lupberger, J., M. B. Zeisel, F. Xiao et al. “EGFR and EphA2 Are Host Factors for Hepatitis C Virus Entry and Possible Targets for Antiviral Therapy.” Nat Med 17, no. 5 (2011): 589–95.
113. Zemni, R., T. Bienvenu, M. C. Vinet et al. “A New Gene Involved in X-Linked Mental Retardation Identified by Analysis of an X;2 Balanced Translocation.” Nat Genet 24, no. 2 (2000): 167–70.
114. Bassani, S., and M. Passafaro. “Tspan7: A New Player in Excitatory Synapse Maturation and Function.” Bioarchitecture 2, no. 3 (2012): 95–7.
115. Nikopoulos, K., C. Gilissen, A. Hoischen et al. “Next-Generation Sequencing of a 40 Mb Linkage Interval Reveals Tspan12 Mutations in Patients with Familial Exudative Vitreoretinopathy.” Am J Hum Genet 86, no. 2 (2010): 240–7.
116. Junge, H. J., S. Yang, J. B. Burton et al. “Tspan12 Regulates Retinal Vascular Development by Promoting Norrin- but Not Wnt-Induced FZD4/Beta-Catenin Signaling.” Cell 139, no. 2 (2009): 299–311.
117. Khattree, N., L. M. Ritter, and A. F. Goldberg. “Membrane Curvature Generation by a C-Terminal Amphipathic Helix in Peripherin-2/rds, a Tetraspanin Required for Photoreceptor Sensory Cilium Morphogenesis.” J Cell Sci 126, no. 20 (2013): 659–70.
118. Duncan, J. L., K. E. Talcott, K. Ratnam et al. “Cone Structure in Retinal Degeneration Associated with Mutations in the Peripherin/RDS Gene.” Invest Ophthalmol Vis Sci 52, no. 3 (2011): 1557–66.
119. Goldberg, A. F., and R. S. Molday. “Defective Subunit Assembly Underlies a Digenic Form of Retinitis Pigmentosa Linked to Mutations in Peripherin/RDS and ROM-1.” Proc Natl Acad Sci U S A 93, no. 24 (1996): 13726–30.
120. Boesze-Battaglia, K., F. P. Stefano, C. Fitzgerald, and S. Muller-Weeks. “ROM-1 Potentiates Photoreceptor Specific Membrane Fusion Processes.” Exp Eye Res 84, no. 1 (2007): 22–31.
121. Clarke, G., A. F. Goldberg, D. Vidgen et al. “ROM-1 Is Required for Rod Photoreceptor Viability and the Regulation of Disk Morphogenesis.” Nat Genet 25, no. 1 (2000): 67–73.
122. Karamatic Crew, V., N. Burton, A. Kagan et al. “CD151, the First Member of the Tetraspanin (TM4) Superfamily Detected on Erythrocytes, Is Essential for the Correct Assembly of Human Basement Membranes in Kidney and Skin.” Blood 104, no. 8 (2004): 2217–23.
123. Mollinedo, F., G. Fontan, I. Barasoain, and P. A. Lazo. “Recurrent Infectious Diseases in Human CD53 Deficiency.” Clin Diagn Lab Immunol 4, no. 2 (1997): 229–31.
124. Figdor, C. G., and A. B. van Spriel. “Fungal Pattern-Recognition Receptors and Tetraspanins: Partners on Antigen-Presenting Cells.” Trends Immunol 31, no. 3 (2010): 91–6.
125. Hemler, M. E. “Targeting of Tetraspanin Proteins—Potential Benefits and Strategies.” Nat Rev Drug Discov 7, no. 9 (2008): 747–58.
126. Hassuna, N., P. N. Monk, G. W. Moseley, and L. J. Partridge. “Strategies for Targeting Tetraspanin Proteins: Potential Therapeutic Applications in Microbial Infections.” BioDrugs 23, no. 6 (2009): 341–59.